Cytokinetics, Incorporated · NASDAQ:CYTK
Malik Fady Ibraham sold 3,500 Cytokinetics, Incorporated shares (Form 4)
Traded Oct 20, 2026 · Filed Oct 20, 2026
On Oct 20, 2026, Malik Fady Ibraham (EVP Research & Development) sold 3,500 Cytokinetics, Incorporated shares at US$64.01 for US$224K under a trading plan, leaving 153,902 shares. Filed Oct 20, 2026 (Form 4).
- Sold
- 3,500 shares
- Price
- US$64.01
- Value
- US$224K
- Holding after
- 153,902 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP Research & Development
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Common Stock | Option exercise | 3,500 | US$7.80 | 157,402 | Direct |
| Oct 20, 2026 | Common Stock | Sale | 3,500 | US$64.01 | 153,902 | Direct |
Source
Download original · View original at SEC
Related
- Cytokinetics, Incorporated
- Malik Fady Ibraham
- Cytokinetics, Incorporated shareholders
- Form 4 · Malik Fady Ibraham · Oct 6, 2026
- Form 4 · Malik Fady Ibraham · Sep 22, 2026
- Form 4 · Malik Fady Ibraham · Sep 8, 2026
- Form 4 · Malik Fady Ibraham · Aug 18, 2026
- Form 4 · Malik Fady Ibraham · Jul 23, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026
- Form 4 · Kaye Edward M. MD · Oct 20, 2026